Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Promising cancer treatments were found, but the manufacturer closed.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Targeting EGFR may help reduce hair loss from chemotherapy.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

A new hydrogel treatment reduces inflammation and promotes hair growth in alopecia areata.

No treatment fully prevents hair loss from chemotherapy yet.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Targeting the Smoothened receptor shows promise for treating certain cancers.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.